Benitec Biopharma Limited
BNTCW
BNTCW was delisted on the 14th of April, 2020.
3 hedge funds and large institutions have $42K invested in Benitec Biopharma Limited in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
16% less capital invested
Capital invested by funds: $50K → $42K (-$8K)
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $27K | – | – | – |
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $15K | – | – | – |
|
BNTCW Hedge Fund Activity: Q3 2017 in Review
3 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Benitec Biopharma Limited (BNTCW) for Q3 2017, worth a combined $42K — down 16% from $50K a quarter earlier.
Fund positioning in BNTCW was balanced in Q3 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
- 3 institutional investors held Benitec Biopharma Limited (BNTCW) as of Q3 2017, unchanged from Q2 2017.
- Funds reported $42K of Benitec Biopharma Limited stock for Q3 2017, down 16% quarter-over-quarter.
- 0 funds opened new Benitec Biopharma Limited positions in Q3 2017 and 0 closed out.
Based on aggregated 13F filings for Q3 2017.